WHAT THIS PAPER ADDS This study shows that the prevalence of chronic venous disease (CVD) is high, is currently underestimated and that prevalence increases with age. Risk factors and symptomatology were evaluated. CVD results in impaired quality of life and losses in productivity. Awareness of this disease must be improved among patients, healthcare professionals, and authorities.
INTRODUCTION
Chronic venous disease (CVD) is one of the most common disorders in northern and western Europe. 1e4 Estimates of its prevalence vary based on population, selection criteria, disease definition, and imaging techniques; however, prevalence has been shown to increase with age. 1e3 In a population based study (Bonn Vein Study 5, 6 ), classification levels (CEAP-classification) were 59.0% C1, 14.3% C2, 13.5% C3, 2.9% C4, and 0.7% C5-C6. The estimated prevalence in the UK adult population ranges from 20% to 40%. 7 The age stratified prevalence of truncal varicose veins measured in the Edinburgh Vein study was 11.5% in the 18e24 age group, increasing to 55.7% in the 55e64 age group. 2, 8 The etiology of varicose veins remains unclear, 3 but is likely to be multifactorial and includes, although unproven, 1,9 a moderate to strong genetic component. 10 Valve damage and abnormal elastic properties, leading to increased venous pressure and distention, are the most common etiology for primary varicose veins. 11, 12 Risk factors include high intravenous pressure (caused by standing for long periods), sedentary lifestyle, pregnancy, gender, and family history. Obesity itself is usually not considered a risk factor; however, obese people with varicose veins have more symptoms 13 and a higher complication rate. 1 Smoking in men has also been shown to be a risk factor. 14 Previous deep vein thrombosis (DVT) is the most frequent cause of secondary varicose veins. 3, 11 In an attempt to provide a better understanding of the worldwide prevalence of CVD in general practice and thus to improve the awareness of this chronic disease among patients, healthcare professionals, and authorities, a global initiative has been launched: the Vein Consult Program (VCP). This international, observational, prospective epidemiological survey is carried out under the auspices of the Union Internationale de Phlébologie (UIP). The VCP is the largest worldwide CVD detection program ever undertaken and it has been conducted in many countries. 15e19 It collects epidemiological data on the prevalence of CVD symptoms, signs, CEAP classes, quality of life, and costs.
The protocol used is identical for all countries, including the use of the C clinical classification. This ensures that the data collected on reporting, diagnosis, and treatment of CVD are consistent and can be compared worldwide.
The present study details the results from the VCP for Belgium and Luxembourg, and additional analysis has been carried out with regard to risk factors and symptoms.
MATERIALS AND METHODS
Patients were recruited by 406 selected GPs (general practitioners) between May 1, and September 15, 2013. GPs were selected in compliance with national regulations, usually at random from a national registration list. Each investigator included 10e20 consecutive patients who attended the practice for various reasons. The minimum age was 18 years. Patients attending for emergency visits were excluded. Informed consent was obtained from each participant. First, the patient was interviewed by the GP: information regarding age, gender, height, occupation, body mass index (BMI) as possible risk factors, was collected using a questionnaire (consultation records form). These possible risk factors include family history of CVD, personal history of blood clots in leg veins, hours spent standing and sitting, number of hours of exercise daily, and smoking. Among women the number of births, current pregnancy, and use of birth control pills and hormonal replacement therapy was recorded. The GP asked the patients about the presence of symptoms of CVD (heavy legs, pain in the legs, sensation of swelling or burning, night cramps, itching, sensation of pins and needles) and possible signs of CVD (current problems with swollen legs, spider veins, varicose veins, or ankle ulcers). Current or past medical treatment for leg problems was also recorded.
Second, the GP scored the patients according to the Cclassification by visual examination. The GPs received an illustrated guide on the C-classification to ensure they adequately reported the C-class of each patient in the case report form. Diagnoses of CVD in patients were made by the GP. No ultrasound examination was done. Patients diagnosed with CVD filled in an additional quality of life (QoL) questionnaire (CIVIQ-14). CIVIQ-14 is a reliable, valid, and sensitive instrument applicable to international studies of patients with chronic venous disease. 20, 21 The results from the QoL questionnaire were transformed into a Global Index Score (GIS, the difference between the final score and the minimum possible score, divided by the difference between the theoretical maximum and minimum scores, multiplied by 100). The score ranges from 0 (worst QoL) to 100 (best QoL). Any history of previous treatment and consequential incapacity to work was also noted. The survey was approved by the ethics committee of the University Hospital of Brussels (UZ Brussels) and the ethics committee of Luxembourg (CNER).
Statistical analysis
The Proc freq SAS procedure with Cochran-Mantel-Haenszel (CMH) statistics was used for data analysis. To compare continuous and ordinal outcomes between groups, Mann-Whitney U tests were applied (SPSS version 22). To investigate the relationship between CEAP classification and symptoms as to the influence of risk factors on the severity of CVD, corrected for age and gender, a logistic regression was performed. A Spearman test was used to calculate possible correlations. For all tests, a p value <.05 was considered to be statistically significant.
RESULTS 6009 patients were included in the survey. The mean age was 53.4 (AE17.6) years, with 67.5% female. The average BMI was 26.08 (AE5.25) with no statistical gender difference.
According to clinical examination by the GP, 61.3% (C1-C6) and 75.2% (C0s-C6) of the patients had chronic venous disease and 25.9% of the patients had chronic venous insufficiency (CVI) (C3-C6) ( Table 1 ). There was an active ulcer in 0.9% of patients. In 15.2% of the patients, the current consultation was performed for leg vein problems.
When the GP was asked whether the patient had CVD, a positive answer was given in only 45.9% of cases, meaning that the prevalence of CVD was underestimated.
64.7% of the patients had symptoms of CVD, with heavy legs, pain, sensation of swelling, and night cramps being the most frequent symptoms, which were obvious in the evenings or after prolonged standing ( Table 2 ). Among symptomatic patients, 20.6% had more than three different symptoms. 46.4% of patients had a positive family history of CVD (most common risk factor).
According to the GPs, 49.5% of the total patient group needed treatment for their CVD. These treatments were, in order of decreasing frequency: lifestyle advice, venoactive drugs, compression therapy, invasive treatment (sclerotherapy, endovenous ablation, and surgery), and anticoagulation. Only 11% of patients were referred to a venous specialist, while 6.5% were already under specialist care.
Based on a Mann-Whitney U test, the C-classification was significantly higher for females than for males (p < .001). Furthermore, a significant positive Spearman correlation (p < .001 in both groups) was observed between age and Cclass for women (Spearman correlation ¼ 0.42) and men (Spearman correlation ¼ 0.41) ( Fig. 1) .
Both gender and age were significantly related to C-class, so additional logistic regression testing was used to correct for that influence when testing the effect of risk factors for a higher C-class. Among women, but only in the 18e34 age group, patients taking birth control pills had a significantly lower C-class compared with females not taking them (p ¼ .022) ( Fig. 2) . A weak (positive) but significant correlation was identified between number of pregnancies and C-class, which existed in each of the age groups. Also, a significant positive correlation was found between BMI and the severity of CVD (C-classification) for all age groups and both genders (Fig. 3) .
For all age groups and for both genders, C-class was significantly higher (p < .05 or less) for the "no regular exercise" group compared with the "regular exercise group". It was only for males aged between 18 and 34 that no significant effect was found (p ¼ .054; however, the results point in the same direction, Fig. 4) . Also, the most common risk factor, a positive family history of CVD, correlates with a higher C-class for both age groups and genders (p < .001, Fig. 5 ).
Of the whole patient population, 41.6% were smokers (current or past), and based on a Mann-Whitney U test, patients with that risk factor had a significantly higher C class compared with non-smokers (Fig. 6 ).
The number of symptoms correlates with a higher C class (Table 3) , especially for grades C3-C6 (compared with C0s-C2). Logistic regression using C class C3-C6 as a binary predictor and correcting for age, gender, and significant interaction between these was performed. Patients with a higher C classification (C3-C6) have significantly more pain in the legs (p < .001), and a significantly higher probability of reporting heavy legs (p < .001), a sensation of swelling (p < .001) and burning (p < .001), compared with the group with C-classification <3.
An association was also found between a higher C-class (C3-C6) and experiencing night cramps (p < .001), itching (p < .001), and having the sensation of pins and needles (p < .001).
Patients with a positive diagnosis of CVD were asked to fill in a quality of life questionnaire (CIVIQ-14). These data were recalculated into a GIS (0e100). GIS is not approximately normally distributed. Non-parametric methods were used. A total of 3432 valid answers were obtained and the median score in the total population was 86 (mean 80.59 AE 19.26). Male patients had a significantly better GIS compared with female patients (median 94 vs. 84, p < .001). In both females and males, age was negatively correlated with GIS (p < .001). Mann-Whitney U tests and Spearman correlations were calculated separately for each age group and by gender. In all age groups and for both genders, GIS are significantly lower for the patients with a positive family history, patients with a history of thrombophlebitis, and patients with a higher BMI compared with patients without these risk factors (p < .001).
A significant negative correlation was found between Cclassification and GIS for both genders in all age groups. Higher C-classes are significantly associated with lower GIS ( Table 4 , p < .001).
Another significant negative correlation was found between the number of symptoms and the QoL (GIS) (p < .001).
Among those patients with a diagnosis of CVD, 2.1% had made changes to their professional activities because of venous leg problems. In 9.4% of cases, hospitalization was necessary because of venous leg problems. Of these patients (positive CVD), 10.4% reported a loss of working days, with these losses being less than 1 week (37.8%), between 1 week and 1 month (30.2%), and more than 1 month (17.2%) (with 14.8% unknown).
DISCUSSION
The Vein Consult Program (VCP) has been carried out in many countries. 15e19 The advantage of the VCP is that the same protocol has been used in each participating country, which makes it possible to compare the results. In this survey, however, more statistical analysis was added concerning symptomatology and risk factors. Possible correlations between these risk factors and the severity of CVD (CEAP classification) were examined. Any possible association with QoL (GIS) was also assessed. The prevalence of CVD was 75.2% (C0s-C6), which is very high. This result does, however, include patients with a C0s level. This may be disputable as some of the symptoms could be the result of non-CVD disorders. Symptoms such as night cramps, restless legs, and heavy legs are not always caused by venous disease. Very often, it is not possible to make a distinction between the cause of these symptoms (C0s) especially in a GP practice, without performing any additional examinations such as duplex-ultrasound. Hence considering C0s patients with a limited number of symptoms as suffering from CVD, leads to an overestimation of measured CVD prevalence. The percentage of C1-C6 patients in this survey was 61.3%, which is comparable to 15, 19 or higher 16, 18 than the percentages from similar surveys in other countries. In those surveys where the percentage of C1-C6 patients was lower, the mean age of patients was lower as well.
This survey measured the prevalence of CVD in a population visiting a GP. This population does not exactly represent the average population in Belgium and Luxembourg. The mean age (53.4 years) of the study population is higher than the mean for the Belgian population (40.35 years, economie.fgov.be). The female predominance (67.5%) is also higher. These differences influence the measured prevalence of CVD.
In this survey CVD was measured using the C-classification (only the C from CEAP). This classification is commonly used in clinical practice. However, the reproducibility of this C-classification is moderate, 22 especially if used by GPs who are not in the habit of working with it.
When GPs were asked whether the patient being examined had CVD, a positive answer was given in 45.9% of cases, but the prevalence of CVD in Belgium and Luxembourg (including the C0s to the C6 patients) is 75.2%. Such discrepancy can be explained as most of the GPs do not consider C0s and C1 patients to be patients with disease. Only 7.8% and 40.5% of the C0s and C1 patients, respectively, were considered by their GPs to have a CVD, with actual figures raised to more than 80% from C2 and up to 94.3% at C5 (sample size at C6 is too small for comparison). The interpretation of such results is that it is not until patients have varicose veins (C2) that GPs consider they have a CVD. In other words, they do not consider early stages of CVD (i.e. C0s and C1) as part of the disease.
The GPs referred 11% of the patients to a vein specialist, while 6.5% were already under specialist care. This referral was related to a higher C-class. Probably, GPs are not always convinced that patients having a lower C-class need to be referred to a specialist. They might believe that they can help those patients with conservative treatment. In 49.5% of patients, a treatment was proposed: lifestyle advice (78.6%), venoactive drug (69.3%), compression therapy (42.2%), and anticoagulation therapy (14.1%).
A significant correlation was found between age and severity of CVD. This relationship is upheld by many epidemiological studies, 1, 3 and is most likely the result of increased pressure on superficial veins caused by weakening of calf muscles coupled with the gradual deterioration of vessel walls over time. 3 Although the prevalence of varicose veins is usually reported to be greater in women, 3,23e25 results in relation to CVI have been inconsistent. Some studies have shown the prevalence of CVI to be higher in men, 2, 23, 26 whereas others have reported a higher prevalence in women 27, 28 or no difference at all. 16 The present study found that female patients had a significantly higher C-class compared with men. There was also a significant correlation between the number of pregnancies and the severity of CVD (in all age groups). Although not consistent, 28 pregnancy is presumed to be a major contributory factor in the increased incidence of varicose veins in women. 29 Pregnancy is associated with a number of physiological changes, which probably contribute to the development of venous distention and potentially to varicose veins. There is a significant increase in blood volume, which is primarily caused by plasma volume expansion. 3 In addition, fetal growth and weight gain increase intra-abdominal pressure and impair venous return. 30, 31 Hormonal changes, such as an increase in relaxin and progesterone levels, will also weaken the blood vessel wall and have a vasodilator effect. 31 This will increase the pressure on the venous valves in the lower limbs.
Risk factors such as obesity 32 (increased intra-abdominal pressure) and lack of regular exercise (decreased calf pump function) increase the venous pressure and thus impair the venous flow. These arguments are supported by the present findings, as a positive significant correlation was noted between BMI, absence of regular exercise, and the severity of CVD (with the exception of males in the 18e34 year age group).
The most common risk factor was a family history of CVD. Of all the patients examined, 55.2% had a positive family history, particularly relating to the mother (mother only in 65.1% of patients with a positive history). This raises a question about the heritability of CVD. The heritability of CVD is high, which suggests a notable genetic component in the etiology of the disease. 28, 33 This conclusion, however, should be interpreted with care, as these results are from a questionnaire. As in many other reports, this survey relies on self reported family history without validation by clinical examination of family members.
Smoking (currently or in the past) is considered a possible risk factor for varicose veins. 8 However, a positive correlation could be found only in males between the ages of 35 and 65 years old. The present data did not reveal any relationship between smoking and the severity of CVI in females.
In the present survey 64.7% of all enrolled patients had at least one symptom. The most common symptoms were heavy legs (in 45.6% of symptomatic patients), pain in the legs (34.9%), sensation of swelling (34.1%) and night cramps (30.1%). A positive correlation was found between the number of symptoms and the C-class (Table 3) . Patients with a higher average C-class (C3-C6) on average have more symptoms. A negative correlation was found between the C-class and quality of life (GIS, Table 4 ). This proves that patients with symptoms of varicose veins have an impaired QoL. QoL decreases from the very first symptoms of CVD and with the cumulative number of symptoms. The QoL impairment is linked to the severity of CVD (Cclassification).
In 2013 39,607 (www.inami.fgov.be) vascular interventions were performed for venous disease in Belgium (total population of 11,099,554). Surgical procedures for varicose veins are among the most frequently performed interventions. In this survey, in the patient group with diagnosed CVD, 10.4% had time off work because of venous disease. In that group, 17.2% lost working time of more than 1 month. This resulted in an important number of days of incapacity to work. It was noted that 0.9% of all the patients had a C6-classification. Venous ulcers are painful 34 and difficult to treat. In a population study in the UK, the median duration of ulceration was 9 months, 20% of ulcers had not healed within 2 years, and 66% of patients had episodes of ulcerations lasting longer than 5 years. 35 Their treatment imposes important costs and significantly impairs quality of life. The impact of CVD on public health budgets is considerable. Treatment of venous incompetence can aid healing and prevent the recurrence of ulcers. 36, 37 It therefore seems reasonable to speculate that such treatments could reduce the risk of ulcers if performed early in the course of CVD. 38 CONCLUSION CVD is a very common and underestimated disease. Its prevalence increases with age. This study found that female patients had a significantly higher C-class compared with men. There is an association between BMI, absence of regular exercise, number of pregnancies, a positive family history, and the severity of CVD. QoL decreases from the very first symptoms of CVD and with the cumulative number of symptoms. CVD generates incapacity to work and worsens patients' quality of life.
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